Grants

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) (RFA-NS-23-012)

Tools

Back to the Top

Sponsor

National Institutes of Health

Award

NINDS intends to commit up to $75,000,000 in FY 2023 to fund 3-5 awards.

Due Date

Letter of Intent due February 23, 2023. Application due March 23, 2023.

View Grant